Grand Rounds

Mass General Cancer Center Grand Rounds is a CME accredited weekly seminar series. Cutting edge topics, case studies and conference highlights will be presented.

Location: Simches Research Center, Room 3110
Start time: 12:00 PM - 1:00 PM

The Massachusetts General Hospital Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research. 


Partners HealthCare System is accredited by the Accreditation Council for Continuing  Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent  of their participation in the activity.

Provided by Partners HealthCare and Massachusetts General Hospital


PLEASE NOTE: Mass General Cancer Center Grand Rounds are open only to MGH Staff and Faculty.

Calendar of Events 2014-2015
ASCO Review
October 2, 2014

Anna Farago, MD, PhD
Thoracic Oncology Center
Massachusetts General Hospital Cancer Center
Instructor in Medicine
Harvard Medical School
Steven Isakoff, MD, PhD
Massachusetts General Hospital Cancer Center
Eunice Kwak, MD, PhD
Massachusetts General Hospital Cancer Center
Richard J. Lee, MD, PhD
Genitourinary Cancer Center
Massachusetts General Hospital Cancer Center
Lipika Goyal, MD
Massachusetts General Hospital Cancer Center


Biomarker-Driven Trials in GI Cancers
October 9, 2014

Wells A. Messersmith, MD
Professor and Co-Division Head, Division of Medical Oncology
University of Colorado School of Medicine


Adherence to Oral Chemotherapy in Patients with Cancer
October 16, 2014

Joseph Greer, PhD
Clinical Assistant in Psychology
Massachusetts General Hospital


Lessons from the Study of Extraordinary Responders
October 23, 2014
David B. Solit, MD
Associate Member
Memorial Sloan-Kettering Cancer Center
Associate Professor of Medicine, Cell and Developmental Biology
Weill Cornell Medical College


Targeting PIK3CA-Mutant Advanced Solid Tumors
October 30, 2014
Dejan Juric, MD
Director of Translational Research, Termeer Center for Targeted Therapies
Massachusetts General Hospital


Clinical Pathologic Conference
November 13, 2014
Speakers TBD


Targeting the tumor microenvironment to improve cancer therapy
November 20, 2014
Michael T. Hemann, PhD
Associate Professor of Biology
Koch Institute for Integrative Cancer Research


Endpoints and Oncology Drug Development: Providing Substantial Evidence of Efficacy
December 4, 2014
Paul G. Kluetz, MD
Acting Deputy Office Director
Office of Hematology and Oncology Products
U.S. Food and Drug Administration


Using Genetically Engineered Mouse Models to Study Sarcoma and Radiation Biology
December 11, 2014
David G. Kirsch, MD, PhD
Associate Professor Radiation Oncology
Associate Professor of Pharmacology and Cancer Biology
Duke University School of Medicine


Novel Therapeutic Opportunities for CDK and PARP Inhibition in Cancer
December 18, 2014
Geoffrey Shapiro, MD, PhD
Director, Early Drug Development Center
Associate Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute


ASH Review
January 8, 2015

Jeremy Abramson, MD
Clinical Director, Center for Lymphoma
Massachusetts General Hospital Cancer Center

Areej El-Jawahri, MD
Massachusetts General Hospital Cancer Center

Amir T. Fathi, MD
Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine
Harvard Medical School

Elizabeth K. O’Donnell, MD
Massachusetts General Hospital Cancer Center



Title TBD
January 15, 2015
Nima Sharifi, MD
Kendrick Family Chair for Prostate Cancer Research
Cleveland Clinic


Titile TBD
January 22, 2015
Glenn Dranoff, MD
Professor, Department of Medicine
Harvard Medical School
Director, Human Gene Transfer Laboratory Core
Co-Leader, Cancer Vaccine Center
Dana-Farber Cancer Institute



The Association between Germline and Acquired Alterations in Glioma Development
January 29, 2015
Robert B. Jenkins, MD, PhD
Professor of Laboratory Medicine & Pathology
Mayo Clinic


Title TBD
February 12, 2015

Nir Hacohen, PhD
Principal Investigator, Center for Immunology and Inflammatory Diseases
Associate Immunologist, Department of Medicine
Massachusetts General Hospital

Title TBD
February 26, 2015

J. Evan Sadler, MD, PhD
Chief, Division of Hematology
Department of Medicine
Washington University

Clinical Pathologic Conference
March 5, 2015

Speakers TBD

Title TBD
March 12, 2015

Priscilla Brastianos, MD
Instructor, Department of Medicine
Harvard Medical School
Assistant in Medicine, Hematology/Oncology
Massachusetts General Hospital Cancer Center

Title TBD
March 19, 2015

Stephen Nimer, MD
Director, Sylvester Comprehensive Cancer Center Professor of Medicine, Biochemistry & Molecular Biology
Professor of Medicine
University of Miami Health System

Title TBD
March 26, 2015

Andrew D. Zelenetz, MD, PhD
Vice Chair, Medical Informatics, Department of Medicine
Memorial Sloan-Kettering Cancer Center

Title TBD
April 16, 2015

Ralph Hruban, MD
Director of the Sol Goldman Pancreatic Cancer Research Center
Professor of Pathology
Johns Hopkins University School of Medicine

Title TBD
April 30, 2015

James C. Yang, MD
Senior Investigator
Center for Cancer Research
National Cancer Institute


Clinical Pathologic Conference
May 7, 2015

Speakers TBD



Title TBD
May 14, 2014

Nabeel El-Bardeesy, PhD
Assistant Professor
Massachusetts General Hospital Cancer Center



Title TBD
May 21, 2015

Mignon Loh, MD
Assistant Professor
Professor of Clinical Pediatrics
Deborah and Arthur Ablin Endowed Chair in Pediatric Molecular Oncology
Division Chief Hematology Oncology
University of California Benioff Children's Hospital, San Francisco




Molecular Pathology of Acute Leukemia
May 28, 2015
(this session co-sponsored with the Pathology Department)

James R. Downing, MD
Member, St. Jude Faculty
President and Chief Executive Officer, St. Jude Children's Research Hospital
Associate Director of Basic Research, Cancer Center
Donald Pinkel Chair of Childhood Cancer Treatment
Director, Molecular Pathology Laboratory


Among the best in the nation for cancer care

U.S. News & World Report ranks the Mass General Cancer Center in the top 10 among U.S. hospitals.


Learn about targeted therapy clinical trials

Visit for more information on the latest genomic research, cancer treatments and clinical trials.

Support the Cancer Center

Your gift of any amount will help us in our mission to advance knowledge and to rapidly translate discovery into exceptional cancer care. Learn more about making a gift, including tribute giving and other ways to get involved.